Canadian Vital Statistics Death Database Research Articles

Trends in Suicide Mortality in Canada by Sex and Age Group, 1981 to 2017: A Population-Based Time Series Analysis: Tendances de la mortalité par suicide au Canada selon le sexe et le groupe d'âge, 1981 - 2017 : Une analyse de séries chronologiques dans la population.

Objectives:Suicide is a complex global public health issue. The objective of this study was to assess time trends in suicide mortality in Canada by sex and age group.Methods:We extracted data from the Canadian Vital Statistics Death Database for all suicide deaths among individuals aged 10 years and older based on International Statistical Classification of Diseases and Related Health Problems, Ninth Revision (E950-959; 1981 to 1999) and International Statistical Classification of Diseases and Related Health Problems, 10th Revision (X60-X84, Y87·0; 2000 to 2017) for a 37-year period, from 1981 to 2017. We calculated annual age-standardized, sex-specific, and age group-specific suicide mortality rates, and used Joinpoint Regression for time trend analysis.Results:The age-standardized suicide mortality rate in Canada decreased by 24.0% from 1981 to 2017. From 1981 to 2007, there was a significant annual average decrease in the suicide rate by 1.1% (95% confidence interval, −1.3 to −0.9), followed by no significant change between 2007 and 2017. From 1981 to 2017 and from 1990 to 2017, females aged 10 to 24 and 45 to 64 years old, respectively, had a significant increase in suicide mortality rates. However, males had the highest suicide mortality rates in all years in the study; the average male-to-female ratio was 3.4:1.Conclusion:The 3-decade decline in suicide mortality rates in Canada paralleled the global trend in rate reductions. However, since 2008, the suicide rate in Canada was relatively unchanged. Although rates were consistently higher among males, we found significant rate increases among females in specific age groups. Suicide prevention efforts tailored for adult males and young and middle-aged females could help reduce the suicide mortality rate in Canada.

Abstract P264: Cardiovascular and Cardiometabolic Post-hospitalization Mortality Rates are Not Associated With Traditional Risk Factors and Socioeconomic Status at the Population Level in Canada

Background: While existing literature has established individual risk factors for early death post-hospitalization in patients with cardiovascular and cardiometabolic disease (CVD/CMD), few studies to date have examined whether the known effects of these risk factors are maintained at the population level. The aim of this study was to determine whether traditional CVD risk factors and socioeconomic factors at the population level impacted CVD/CMD post-hospitalization mortality rates in Canada over time. Methodology: We conducted an ecological, cross-sectional analysis using merged data from two sources: 1) the Canadian Community Health Survey 2000-2011 and, 2) the Canadian Vital Statistics Death Database linked to the Discharge Abstract Database 2000-2012. The study outcome was 1-year mortality rate after hospital discharge for CVD/CMD, calculated by census division (CD) using ICD-9-CA codes for hospitalizations and deaths. The first stage of the statistical analysis reported age- and sex-standardized 1-year mortality rates after hospital discharge for CVD/CMD, across CDs in Canada. The second stage utilized Poisson regression to model associations between traditional CVD risk factors and socioeconomic factors at the CD level and CVD/CMD post-hospitalization mortality rates in Canada over time. Results: National 1-year mortality rates in patients with CVD/CMD increased from 146.5 per 100,000 in 2000 to 150.4 in 2012, peaking at 202.4 in 2006, with no significant trend observed over time. Maps of average 1-year mortality rates over the time period (2000-2012) show wide variations in rates across census divisions (CDs) in Canada. Nova Scotia and Ontario had the highest proportion of CDs with worsening rates of mortality over time (3% and 7% respectively) that remained below the national average. Traditional CVD risk factors, demographic factors and socioeconomic factors at the census division level were not associated with 1-year mortality rates after hospital discharge for CVD/CMD over time. Potential implication: Reductions in the CVD/CMD post-hospitalization mortality burden at the individual level may benefit from treatment targeted towards traditional risk factors and socioeconomic factors however; reduction in post-hospitalization burden at the population level can benefit from policy focused towards other societal elements such as healthcare and community care resources.

Changing trends in thyroid cancer incidence in Canada: A histologic examination, 1992 to 2016.

Age-standardized incidence rates (ASIRs) of thyroid cancer (TC) have increased in many parts of the world, primarily because of increased papillary TC detection. While rapid increases in TC incidence have also been reported in Canada, an analysis of incidence and survival by histologic subtype has been lacking. Moreover, recent data points in Canada suggest that the era of rapid annual increases may have ended. Data are from the Canadian Cancer Registry, the Canadian Vital Statistics-Death Database and an analytic file linking the two. Annual percent changes (APCs) in incidence and mortality rates are estimated using Joinpoint regression. Net survival (NS) is derived using the Pohar Perme estimator. Among females, TC ASIRs decreased by 3.0% annually from 2012 to 2016, following years of rapid growth. Among males, a long period of rapid increase ended in 2012 with no subsequent decline. For both sexes the overall incidence trend was driven by changes over time in papillary TC and incidence trends in non-papillary TC varied significantly. From 1992 to 2016, TC mortality rates were stable among females and increased slightly among males (APC = 1.2). Five-year NS was higher among papillary cases (99%) than among non-papillary cases (80%) and among females (99%) than among males (94%). Overall, five-year NS increased by 2.1 percentage points from the period from 1992 to 1996 to the period from 2010 to 2014. The results of this study confirm the central role of papillary TC cases in TC incidence and survival trends in Canada. Given recent changes in trend and TC management guidelines, projected increases in TC rates after 2016 could be re-examined.

Estimation of the impacts of substance use on workplace productivity: a hybrid human capital and prevalence-based approach applied to Canada.

Policy makers require evidence-based estimates of the economic costs of substance use-attributable lost productivity to set strategies aimed at reducing substance use-related harms. Building on a study by Rehm et al. (2006), we provide estimates of workplace costs using updated methods and data sources. We estimated substance use-attributable productivity losses due to premature mortality, long-term disability, and presenteeism/absenteeism in Canada between 2007 and 2014. Lost productivity was estimated using a hybrid prevalence and incidence approach. Substance use prevalence data were drawn from three national self-report surveys. Premature mortality data were from the Canadian Vital Statistics Death Database, and long-term disability and workplace interference data were from the Canadian Community Health Survey. In 2014, the total cost of lost productivity due to substance use was $15.7 billion, or approximately $440 per Canadian, an increase of 8% from 2007. Substances responsible for the greatest economic costs were alcohol (38% of per capita costs), tobacco (37%), opioids (12%), other central nervous system (CNS) depressants (4%), other CNS stimulants (3%), cannabis (2%), cocaine (2%), and finally other psychoactive substances (2%). In 2014, alcohol and tobacco represent three quarters of substance use-related lost productivity costs in Canada, followed by opioids. These costs provide a valuable baseline that can be used to assess the impact of future substance use policy, practice, and other interventions, especially important given Canada's opioid crisis and recent cannabis legalization.

Does geography matter in mortality? An analysis of potentially avoidable mortality by remoteness index in Canada.

The avoidable mortality rate is a key indicator of overall health and health care utilization. However, the avoidable mortality rate may differ by the relative remoteness of a community. Avoidable mortality rates specific to remote areas cannot be investigated unless there is a clear geographic classification of remoteness. Therefore, this research uses a newly developed remoteness index to explore the geographic variability of avoidable mortality in Canada. The remoteness index, Canadian Vital Statistics-Death Database (2011 to 2015), and the 2016 Census of Population are used to understand the geographic variability of preventable and treatable mortality rates in Canada. Descriptive and multivariate data analysis techniques are used to test the hypothesis that remoteness is one of the statistically significant predictors of avoidable mortality rates in Canada. There is a clear gradient of preventable and treatable mortality rates by relative remoteness. The preventable and treatable mortality rates are significantly higher in more remote areas than in easily accessible areas. The remoteness index is a good predictor of both preventable and treatable causes of mortality for low-Aboriginal census subdivisions but not for high-Aboriginal census subdivisions in Canada. Both preventable and treatable mortality rates vary significantly by remoteness, despite Canada's universal health care system. The remoteness of Canadian communities may have affected health care delivery and utilization.

Investigating disparities in cancer by linking the Canadian Cancer Registry to survey and administrative databases: a collaboration between the Canadian Partnership Against Cancer and Statistics Canada

IntroductionThe Canadian Partnership Against Cancer reports on pan-Canadian system performance across the cancer control continuum, including how sociodemographic disparities create barriers in access and utilization of cancer control services. This has been done using mostly ecological data, which does not contain the individual level information required to identify the extent of disparities.
 Objectives and ApproachThe Partnership collaborated with Statistics Canada (STC) to build individual level datasets that will allow researchers to investigate the relationship between sociodemographic factors, cancer outcomes and treatment patterns in Canada.The record linkage was conducted at STC within the Social Data Linkage Environment. Data from the Canadian Cancer Registry were linked to the Discharge Abstract Database, the National Ambulatory Care Reporting System and the Canadian Vital Statistics Death Database to obtain treatment information and deathand death outcomes. To obtain sociodemographic information the following datasets are also being linked: T1 Personal Master File (income), Immigrant Landing File and the Census Long Form (education and geography).
 ResultsLinkage of all datasets is expected to complete by the end of January 2019. For the first time in Canada, record-level linkage of national cancer registry data with key datasets containing sociodemographic information will be available for exploratory analysis. The challenges with linkage and data limitations will be discussed, as well as the application of these linked databases to answer current disparities-related research questions.
 Conclusion/ImplicationsThis initiative illustrates the value of collaboration between data custodians and health researchers as well as how linkage of existing datasets can leverage the full potential of available data, and broaden cancer research in supporting efforts to create a more equitable cancer control system.

Quality assessment of linked Canadian clinical administrative hospital and vital statistics death data

IntroductionThree Canadian clinical-administrative hospital databases were linked to the Canadian Vital Statistics Death Database (CVSD) to provide information about patients who died following discharge from hospital as well as supplementary information about patients that died in-hospital. Quality was assessed using a guided approach and through feedback from initial users.
 Objectives and ApproachThe linked datasets were created to develop and validate health care indicators and performance measures and perform outcome analyses. It is therefore imperative to evaluate the data’s fitness for use. Quality was assessed by calculating coverage of deaths for all linked contributors, creating a profile of the linked dataset and analyzing issues that were identified by users. These analyses were guided by an existing Data Source Assessment Tool, which provides a set of criteria that allow for assessment across five dimensions of quality, thus allowing for appropriate determination of a given set of data’s fitness for use.
 ResultsDeterministic linkage of the datasets resulted in linkage rates that ranged from 66.9% to 90.9% depending on the dataset or data year. Linkage rates also varied by Canadian jurisdictions and patient cohort. Variables had good data availability with rates of 95% or higher. Initial users identified a significant number of duplicate records that were flagged to and corrected by the data supplier. 1.4\% of acute hospital deaths had discrepancies in the death date captured in the two linked sources; the vast majority had a difference of only one day. A user group and issue tracking process were created to share information about the linked data and guarantee that issues are triaged to the appropriate party and allow for timely follow up with the data supplier.
 Conclusion/ImplicationsDocumentation provided by the data supplier was vital to understanding the linkage methodology and its impact on linkage rates. A guided data assessment ensured that strengths and limitations were identified and shared to support appropriate use. Feedback to the data supplier is supporting ongoing improvements to the linkage methodology.

Use of linked data to assess the impact of out-of-hospital deaths on 30-day mortality indicators

IntroductionPublicly reported 30-day mortality indicators in Canada usually only take into account in-hospital deaths recorded in clinical administrative databases. Studies show that the percentage out-of-hospital deaths may account for 24% to 53% of all 30-day mortality, depending on the indicator, however, such assessments have not been done in Canada.
 Objectives and ApproachThe objective of this study was to compare 30-day mortality rates calculated using clinical administrative data only (in-hospital deaths) with rates calculated combining administrative data and Canadian Vital Statistics Death Database (CVSD) that captures both in- and out-of-hospital deaths. We considered mortality following acute myocardial infarction (AMI), stroke and major surgery. Episodes of care were created through linkage of Discharge Abstract Database (DAD) and National Ambulatory Care Reporting System (NACRS). Mortality information on deaths outside of acute care hospitals was obtained from DAD/NACRS-CVSD linked files created by Statistics Canada. Data from Quebec and Yukon were not included in the analysis.
 ResultsThe overall 30-day AMI mortality rate calculated using both DAD and DAD-CSVD linked file was 7.4% compared to 6.7% 30-day in-hospital mortality rate calculated using DAD only. Mortality rates after stroke were 15.8% and 14.0% and after major surgery 1.8% and 1.6%, respectively. The impact of adding out-of-hospitals deaths to rate calculations varied by province and rurality. Adding death data from the DAD-CVSD linked file accounted for 10% of 30-day AMI mortality, 11% of 30-day stroke mortality and 12% of 30-day mortality after major surgery, based on 2011 data. However, depending on the indicator, 7% to 9% of the deaths within 30 days recorded in DAD were not found in DAD-CVSD linked file due to limitations of the linkage methodology.
 Conclusion/ImplicationsAn impact of including out-of-hospital deaths in the 30-day mortality rates appears to be less in Canada (~10%) than shown in other studies. However, while the DAD/NACRS-CVSD linked files provide valuable supplemental information, linkage methodology limitations suggest that they should be used in conjunction with mortality information available in DAD.

Trends in incidence, mortality, and survival for kidney cancer in Canada, 1986-2007.

Purpose Kidney cancer is one of the fastest rising cancers worldwide. We aimed to examine the trends in incidence, mortality, and survival for this cancer in Canada.MethodsIncidence data for kidney cancer for 1986–2010 were from the Canadian Cancer Registry and the National Cancer Incidence Reporting System. These data were only available up to 2007 for the province of Quebec and consequently for the same year nationally, for Canada. Mortality data for 1986–2009 were from the Canadian Vital Statistics Death Database. Changes in age-standardized rates were analyzed by Joinpoint regression. Incidence rates were projected to 2025 using a Nordpred age-period-cohort model. Five-year relative survival ratios (RSR) were analyzed for 2004–2008 and earlier periods.ResultsBetween 1986 and 2007, the age-standardized incidence rate (ASIR) per 100,000 rose from 13.4 to 17.9 in males and 7.7 to 10.3 in females. Annual increases in ASIR were greatest for age groups <65 years (males) and ≥65 years (females). The ASIRs increased significantly over time in both sexes for renal cell carcinoma (RCC) but not for other kidney cancer types. RCC rates are projected to increase until at least 2025. Mortality rates decreased only slightly in each sex since 1986 (0.4 %/year in males; 0.8 %/year in females). The 5-year RSR for kidney cancer was 68 % but differed largely by morphology and age, and has increased slightly over time.ConclusionsThe incidence rate of kidney cancer in Canada has risen since at least 1986, led largely by RCC. Increasing detection of incidental tumors, and growing obesity and hypertension rates are possible factors associated with this increase. Greater prevention of modifiable risk factors for kidney cancer is needed.

Invasive Cervical Cancer Incidence and Mortality Among Canadian Women Aged 15 to 29 and the Impact of Screening

ObjectiveThe utility of screening young women for cervical cancer is questionable given the likelihood of pre-cancer regression and the potential harm of the intervention. Our objective was to determine the incidence and mortality rates of invasive cervical cancer (ICC) in women aged 15 to 29 years and to assess changes in rates since the uptake of screening. MethodsThe incidence of ICC cases from 1970 to 2007 was obtained from records in the Canadian Cancer Registry and from the National Cancer Incidence Reporting System. Mortality rates in women with ICC for the same time period were obtained from the Canadian Vital Statistics Death Database. Data were classified by age group and year at diagnosis or death, assessed at five-year intervals. The incidence was further analyzed according to histology. ResultsICC among 15- to 19-year-olds is rare and has remained relatively constant from 1970–1974 to 2005–2007. From 1975–1979 to 2005–2007, the incidence in 20- to 24-year-olds declined from 3.2 to 1.2 per 100 000. From 1980–1984 to 2005–2007, the incidence in 25- to 29-year-olds declined from 11.1 to 6.3 per 100 000. Deaths among 15- to 19-year-olds and 20- to 24-year-olds are rare, but in 25- to 29-year-olds mortality declined from 0.9 to 0.5 per 100 000 between 1975–1979 and 2005–2007. Among 20- to 24-year-olds, rates of all cervical cancers and squamous cell carcinomas declined, while adenocarcinomas and unknown types were rare. In 25- to 29-year-olds there was a decline in all cervical cancers and squamous cell cancers and an apparent increase in adenocarcinoma. ConclusionsICC in adolescents is rare and does not justify population-based screening. Screening appears to have affected the incidence of ICC in 20- to 24-year olds and incidence and mortality from ICC in 25- to 29-year-olds.

Increasing incidence in liver cancer in Canada, 1972-2006: Age-period-cohort analysis.

Our study aimed to assess 1) the temporal trends in incidence and mortality of liver cancer and 2) age-period-cohort effects on the incidence in Canada. We analyzed data obtained from the Canadian Cancer Registry Database and Canadian Vital Statistics Death Database. We first examined temporal trends by sex, age group, and birth cohort between 1972 and 2006. Three-year period rates and annual percentage change (APC) were calculated to compare the changes over the study period. We used age-period-cohort modelling to estimate underlying effects on the observed trends in incidence. The overall age-adjusted incidence rates increased from 2.6 and 1.5 per 100 000 in 1972-74 to 6.5 (APC: 2.9) and 2.2 (APC: 1.2) per 100 000 in 2004-06 among males and females, respectively. The age-adjusted mortality rates increased from 3.3 and 2.0 per 100 000 in 1972-74 to 6.0 (APC: 2.3) and 2.6 (APC: 1.2) per 100 000 in 2004-06 among males and females, respectively. The incidence increased most rapidly in men aged 45-54 years (APC: 4.1) and women aged 65-74 years (APC: 1.7) over the period of study. The age-period-cohort analysis suggests that birth-cohort effect is underlying the increase in incidence. While the exact reason for the increased incidence of liver cancer remains unknown, reported increase in HBV and HCV infections, and immigration from high-risk regions of the world may be important factors.

Suicide in Newfoundland and Labrador: A Linkage Study Using Medical Examiner and Vital Statistics Data

To examine suicide epidemiology in Newfoundland and Labrador from 1997 to 2001. Data from the Office of the Chief Medical Examiner (CME) were linked with data derived from the Canadian Vital Statistics Death Database. Ninety-five percent confidence intervals (CI) were calculated to assess variation of rates. We used the chi-square test to compare categorical data. The CME recorded 225 suicide deaths, compared with 187 in the Canadian Vital Statistics Death Database. Most deaths not coded as suicide in the national database were coded as accidental. Using the CME data, the overall suicide rate was 9.5/100000, aged 10 years and older. The rate among males (15.8/100 000, 95% CI, 10.7 to 20.8) was almost 5 times that of females (3.3/100000; 95% CI, 1.0 to 5.5). Age-standardized rates decreased over the study period, from 10.9 to 8.0/100000; however, the difference was not significant. The proportionate mortality ratio for suicide deaths was highest among those aged 10 to 19 years (20.0%) and decreased with age. The suicide rate was highest among those aged 50 to 59 years. The rate for unpartnered individuals (17.0/100000, 95% CI, 10.7 to 23.0) was significantly higher, compared with partnered individuals (5.1/100000; 95%CI, 2.5 to 7.8). Males used more violent methods than females. Suicide was significantly higher in Labrador (27.7/100000, 95% CI, 18.4 to 37.0), an area with a higher Aboriginal population, compared with the island of Newfoundland (8.5/100000, 95% CI, 7.3 to 9.7). Psychiatric illness was the most common predisposing factor. Suicide deaths are highest among males, unpartnered individuals, and individuals with psychiatric disorders.